Jobs at risk if EU grants MES to China, by country, ranked by number of jobs at risk
Low impact* | High impact* | ||||
---|---|---|---|---|---|
Rank | Country | Jobs at risk | Jobs at risk as a share of total country employment | Jobs at risk | Jobs at risk as a share of total country employment |
1 | Germany | 319,700 | 0.8% | 639,200 | 1.7% |
2 | Italy | 208,100 | 0.9% | 416,200 | 1.9% |
3 | United Kingdom | 193,400 | 0.7% | 386,800 | 1.4% |
4 | France | 183,300 | 0.7% | 366,800 | 1.5% |
5 | Poland | 145,100 | 1.0% | 290,100 | 1.9% |
6 | Spain | 136,600 | 0.7% | 273,300 | 1.5% |
7 | Romania | 100,100 | 1.2% | 200,100 | 2.5% |
8 | Netherlands | 52,000 | 0.7% | 104,000 | 1.4% |
9 | Czech Republic | 46,900 | 1.0% | 93,900 | 2.0% |
10 | Portugal | 45,700 | 1.1% | 91,400 | 2.1% |
11 | Hungary | 40,500 | 1.1% | 80,900 | 2.2% |
12 | Bulgaria | 38,000 | 1.3% | 76,100 | 2.7% |
13 | Austria | 31,900 | 0.8% | 63,700 | 1.6% |
14 | Greece | 30,700 | 0.8% | 61,300 | 1.5% |
15 | Belgium | 30,700 | 0.7% | 61,300 | 1.4% |
16 | Sweden | 30,400 | 0.7% | 60,700 | 1.4% |
17 | Slovakia | 24,400 | 1.1% | 48,800 | 2.1% |
18 | Finland | 19,400 | 0.8% | 38,900 | 1.6% |
19 | Denmark | 18,900 | 0.7% | 37,800 | 1.5% |
20 | Ireland | 13,700 | 0.8% | 27,500 | 1.5% |
21 | Lithuania | 11,100 | 1.0% | 22,100 | 1.9% |
22 | Slovenia | 9,000 | 1.0% | 18,000 | 2.0% |
23 | Latvia | 6,300 | 0.8% | 12,600 | 1.7% |
24 | Estonia | 5,200 | 1.1% | 10,500 | 2.1% |
25 | Cyprus | 2,400 | 0.6% | 4,800 | 1.3% |
26 | Malta | 1,200 | 0.9% | 2,400 | 1.8% |
27 | Luxembourg | 1,000 | 0.6% | 2,000 | 1.2% |
* The low-impact scenario assumes granting MES to China would increase manufacturing imports from China by 25 percent over the next three to five years relative to their base level in 2011; the high-impact scenario assumes a 50 percent increase in imports from China.
Source: Authors' analysis of Bivens (2014, Table 5), European Commission (2015a, 2015b, 2015c, 2015d, and 2015h). For a more detailed explanation of data sources and computations, see text and the appendix.